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Though the hunger-reduction phenomenon reported during ketogenic diets is well-known,
the underlying molecular and cellular mechanisms remain uncertain. Ketosis has been
demonstrated to exert an anorexigenic effect via cholecystokinin (CCK) release while
reducing orexigenic signals e.g., via ghrelin. However, ketone bodies (KB) seem to be able
to increase food intake through AMP-activated protein kinase (AMPK) phosphorylation,
gamma-aminobutyric acid (GABA) and the release and production of adiponectin. The
aim of this review is to provide a summary of our current knowledge of the effects of
ketogenic diet (KD) on food control in an effort to unify the apparently contradictory data
into a coherent picture.
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INTRODUCTION
Hunger and satiety are two important mechanisms involved in
body weight regulation. Even though humans can regulate food
intake by will, there are systems within the central nervous sys-
tem (CNS) that regulate food intake and energy expenditure. This
complex network, whose control center is spread over different
brain areas, receives information from adipose tissue, the gas-
trointestinal tract (GIT), and from blood and peripheral sensory
receptors. The actions of the brain’s hunger/satiety centers are
influenced by nutrients, hormones and other signaling molecules.
Ketone bodies are the major source of energy in the periods of
fasting and/or carbohydrate shortage and might play a role in
food intake control.
HYPOTHALAMIC CONTROL OF FEEDING/APPETITE/HUNGER
ROLE OF NUTRIENTS IN FOOD INTAKE CONTROL
The hypothalamus is the brain’s main center responsible for
hunger/satiety (H/S) control. In the theory that Mayer proposed
more than 60 years ago, he assigned a central role to glucose lev-
els in the H/S control: the so-called “glucostatic theory” (Mayer,
1955). Mayer suggested that depletion of carbohydrate availabil-
ity leads to hunger, and the hypothalamic centers with receptors
sensitive to glucose levels might be involved in the short-term
regulation of energy intake (Mayer, 1955). The “feeding center”
in the lateral hypothalamic area (LHA), according to the gluco-
static theory, reacts to the between-meal fall of blood glucose and
stimulates food intake. The LHA contains glucose-inhibited neu-
rons that are stimulated by hypoglycemia, a process crucial to
mediating the hyperphagia normally induced by hypoglycemia.
The subsequent post-prandial hyperglycemia activates the “sati-
ety center” in the ventromedial hypothalamus (VMH), which
contains glucose-excited neurons and inhibits both “feeding cen-
ter” and food intake.
In 1953, Kennedy proposed the lipostatic hypothesis sug-
gesting that lipid metabolites could also be involved in food
regulation (Kennedy, 1953), and in 1956, Mellinkoff studied the
effects of protein metabolism suggesting an aminostatic hypothe-
sis (Mellinkoff et al., 1956).
Glucose-sensitive neurons have been identified in a number
of CNS regions including the metabolic control centers of the
hypothalamus. Medeiros et. al. have used patch-clamp electro-
physiology to examine whether neurons in a specific specialized
region known as the subfornical organ (SFO), an area where
the blood-brain barrier is not present, are also glucose sensitive
or not. These experiments demonstrated that SFO neurons are
glucose-responsive and that SFO is an important sensor and inte-
grative center of circulating signals of energy status (Medeiros
et al., 2012).
But comprehensive transcriptional profiling of glucose-
sensing neurons is challenging, as glucokinase (Gck) and other
key proteins that transduce glucose signals are expressed at
low levels. Glucose also exerts a hormonal-like action on neu-
rons; electrophysiological recordings demonstrated, for example,
that hypoglycemia activates growth hormone-releasing hormone
(GHRH) neurons, suggesting a mechanistic link between low
blood glucose levels and growth hormone release (Stanley et al.,
2013).
Nutrient-sensitive neurons reacting to glucose but also to fatty
acids (FAs) concentrations are present at many sites throughout
the brain and may play a key role in the neural control of energy
and glucose homoeostasis. Central administration of oleate, for
example, inhibits food intake and glucose production in rats.
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This suggests that daily variations in plasma FA concentrations
could be detected by the CNS as a signal that contributes to the
regulation of energy balance (Moulle et al., 2014).
Even though intracellular metabolism and activation of the
ATP-sensitive K+ channels appear to be necessary for some sig-
naling effects of FAs, a great amount of the FA responses in the
ventromedial hypothalamic neurons are mediated by interactions
with fatty acid translocase (FAT)/CD36. Translocase is a FA trans-
porter/receptor that activates downstream signaling even in the
absence of intracellular metabolism (Moulle et al., 2014).
The classical unified model is based on the role of the three
metabolic substrates: lipids, glucose and protein/amino acids in
maintaining the nutritional status throughout the corresponding
loci in the CNS, but there are many other signals and brain targets
(Williams et al., 2001).
ROLE OF THE NEUROENDOCRINE SYSTEM IN FOOD INTAKE CONTROL
More recently, other hypothalamic appetite control regions
have been identified, including those in the arcuate nucleus
(ARC), the periventricular nucleus (PVN) and the dorsome-
dial hypothalamic nucleus (DMH) (Valassi et al., 2008). These
are sites of convergence and integration of many central and
peripheral signals, not just macronutrients, that are involved
in food intake and energy expenditure mechanisms, e.g., a
group of neurons in the ARC stimulating food intake via neu-
ropeptide Y (NPY) and agouti gene-related protein (AGRP).
These neurons interact with those producing the anorexigenic
pro-opiomelanocortin (POMC) and the cocaine/amphetamine-
regulated transcript (CART) (Williams et al., 2001). Thus, a more
comprehensive, unified model should include macronutrients as
well as many single amino acids and other signaling molecules.
There are two distinguished types of food intake regulation:
a) the short-term (satiety signals, SS) occurring at the begin-
ning and end of a single meal; it also includes the length between
meals and b) the long-term regulation (adiposity signal, AS) that
is influenced by such factors as body fat deposition.
The SS providing information to the brain mainly send infor-
mation to the nucleus of the solitary tract (NTS). These signals are
generated in the GIT and abdominal viscera, as well as in the oral
cavity and provide information about mechanical and chemical
properties of food. The information is transmitted via vagal and
spinal nerve to the NTS. The ASs arrive to the median eminence
through ARC or through the blood-brain barrier (BBB). All these
afferents are integrated in a complex and not fully understood
network.
Hormones like leptin and insulin, both secreted into the blood,
reflect the stored body fat. These hormones can pass the BBB
and stimulate specific receptors. Hypothalamic areas are richly
supplied by axons from ARC, which has greater concentrations
of leptin and insulin receptors than any other hypothalamic site
(Valassi et al., 2008).
The ARC exerts opposing actions on food intake responding
not only to leptin and insulin, but also to gut hormones (the
most studied are ghrelin and, recently, PYY). The neurophysio-
logical pathways suggest that feeding is regulated by a feedback
loop, where the hypothalamus provides the long-term regulatory
input to the NTS, which acts as a setpoint (Williams et al., 2001).
It has recently been proposed that the ARC is required for
the coordination of homeostatic circadian systems including tem-
perature and activity. Authors tested this hypothesis by injecting
saporin toxin conjugated to leptin into the ARC of rats. Wiater
et al. showed that the leptin-sensitive network is required for
entrainment of activity by photic cues and entrainment of tem-
perature by food but is not required for entrainment of activity
by food or temperature by photic cues (Wiater et al., 2013).
ANOTHER PLAYER: THE GASTROINTESTINAL TRACT AND GUT
MICROBIOTA
The gastrointestinal tract (GIT) plays a central role in the con-
trol of energy balance. Many molecules produced by the GIT
exert hunger or satiety effects on the brain. Ghrelin is a peptide
produced mainly by the stomach’s oxyntic cells that stimulates
ghrelin secretion in the hypophysis and has some neuroendocrine
activities. However, its orexigenic properties are the most rele-
vant to us and ghrelin is the only known peripheral orexigenic
hormone (Date, 2012). Cholecystokinin (CCK) is a peptide pro-
duced mainly in the duodenum and jejunum that acts on the
vagus nerve and directly on the hypothalamic nuclei. CCK is
an anorexigenic factor and it reduces food intake, meal size and
duration (Murphy et al., 2006). Three other related hormones
are pancreatic polypeptide (PP), amylin, and peptide YY (PYY).
PP is a peptide produced by the endocrine pancreas in relation
to the caloric content of meals, and it reduces food intake both
in rodents and humans. Amylin is a peptide co-secreted with
insulin; its main effect on food control is a reduction of meal
sizes and food intake (Murphy et al., 2006). Peptide YY (PYY)
is produced in the gut and is similar to PP. PYY is stored in
intestinal cells and released into the circulation as PYY3−36, a
truncated form of PYY. The release of PYY3−36 is dependent
on a meal’s caloric and fat content (Veldhorst et al., 2008). The
glucagon-like peptide 1 (GLP-1) is produced by the cleavage
of pro-glucagon gene in the intestine. It acts as incretin at a
pancreatic level, promoting insulin secretion and as neuro hor-
mone on hypothalamic nuclei, inducing satiety (Valassi et al.,
2008).
The gut-brain link is important not only for the hormones
produced by the gut, but also for the long-term body weight
regulation. Studies in mice indicate that the gut microbiome
influences both sides of the energy balance by contributing to
nutrient absorption and regulating host genes that affect adi-
posity [however there are conflicting reports (Parks et al., 2013;
Schele et al., 2013)]. However, it remains uncertain just how
important gut microbiota are for nutrient absorption in humans.
A cohort study has demonstrated that the nutrient load is a
key variable that can influence the gut/fecal bacterial content
over short time frames. Furthermore, the observed associations
between gut microbes and nutrient absorption indicates a pos-
sible role of the human gut microbiota in the regulation of the
nutrient intake and utilization (Jumpertz et al., 2011).
Moreover, according to recent evidence, meal onset appears
to be biochemically induced only in the case of serious energy
deprivation, while usually it is controlled by social, cultural and
environmental factors strictly related to the lifestyle (Karatsoreos
et al., 2013).
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SYSTEMIC KETOSIS IN KD THERAPY
Ketogenic diets have become popular in recent decades for their
demonstrated positive effects on weight loss (Bueno et al., 2013),
though the precise mechanism of action is not fully understood
(Paoli, 2014). In fact there is contradictory data about KD in mice
and rats. In fact, there are contradictory data about KD in mice
and rats. For example whilst a huge amount of data confirm that
KD in humans is effective in weight reduction, improving lipi-
demia and glucose tolerance (Bueno et al., 2013), it has been
recently demonstrated that a long-term KD (22 weeks) caused
dyslipidemia, a pro-inflammatory state, hepatic steatosis, glu-
cose intolerance and a reduction in beta and alpha cell mass, all
without weight loss in mice (Ellenbroek et al., 2014). Two con-
siderations should be made: (1) the induction of ketosis and the
response to ketosis in humans andmice are quite different and (2)
mice and humans have different life spans, and results obtained in
mice after several weeks on the diet can correspond to months on
the diet in humans (Demetrius, 2005, 2006).
Regardless of its efficacy for weight loss, the medium-long diet
duration (Paoli et al., 2013) is over-cautiously received by the
physicians, perhaps due to the lack of attention to the topic in
specialized medical education courses. As a result, most physi-
cians associate the term “ketosis” only in the context of diabetic
ketoacidosis.
Meanwhile, the KD induces a ketosis that is not a pathologi-
cal but physiological condition occurring on a daily basis. Hans
Krebs was the first to use the term “physiological ketosis” despite
the common view of it as oxymoron (Krebs, 1966); this physi-
ological condition, i.e., ketosis, can be reached through fasting
or through a drastically reduced carbohydrate diet (below 20 g
per day). In these conditions, glucose reserves become insufficient
both for normal fat oxidation via the supply of oxaloacetate in the
Krebs cycle and for the supply of glucose to the central nervous
system (CNS) (Felig et al., 1969; Owen et al., 1969) (Figure 1). It
is well-known that the CNS cannot use FAs as an energy source
because free FAs cannot cross the blood-brain barrier (BBB).
This is why the brain normally uses only glucose. After 3–4 days
without carbohydrate intake (KD or fasting) the CNS must find
alternative energy sources as demonstrated by Cahill et al. (Owen
et al., 1967, 1969; Felig et al., 1969; Cahill, 2006). These alternative
energy sources are the ketones bodies (KBs): acetoacetate (AcAc),
β-hydroxybutyric acid (BHB) and acetone and the process of their
formation occurring principally in the mitochondrial matrix in
the liver is called ketogenesis (Fukao et al., 2004). Usually the con-
centration of KB is very low (<0.3mmol/L) compared to glucose
(∼=4mmol) (Veech, 2004; Paoli et al., 2010). Since glucose and
KB have a similar KM for glucose transport to the brain the KB
begin to be utilized as an energy source by the CNS when they
reach a concentration of about 4mmol/L (Veech, 2004), which is
close to the KM for themonocarboxylate transporter (Leino et al.,
2001).
KBs can cross the BBB but not in a homogenous manner. For
example, past experiments have demonstrated that BHB utiliza-
tion is different in various brain areas (Hawkins and Biebuyck,
1979). Areas without BBB, hypothalamic regions and the lower
cortical layers have a higher BHB metabolism compared to the
lower one of the basal ganglia (Hawkins and Biebuyck, 1979).
FIGURE 1 | Concentrations of KB: acetone, BHB and acetoacetic acid
(AcAc), and plasma free FAs (FFA) from the post-absorptive state to 40
days of starvation in human subjects. Y axis was expanded to better
describe the great change in BHB concentration. Modified from Fukao et al.
(2004), Owen (2005).
Also the metabolic meaning of the three KBs is different: while
the main KB produced in the liver is AcAc, the primary circu-
lating ketone is BHB. The third one, acetone, is produced by
spontaneous decarboxylation of AcAc, and it is the cause of the
classic “fruity breath.” Acetone does not have any metabolic func-
tions, but it can be used as a clinical diagnostic marker. BHB
acid is not, strictly speaking, a KB because the ketone moiety
has been reduced to a hydroxyl group. Under normal conditions
the production of free AcAc is negligible and this compound,
transported via the blood stream, is easily metabolized by vari-
ous tissues including skeletal muscles and the heart. In conditions
of overproduction, AcAc accumulates above normal levels and
a part is converted to the other two KBs. The presence of KBs
in the blood and their elimination via urine causes ketonemia
and ketonuria. Apart from being the fundamental energy supply
for CNS, glucose is necessary for the replenishment of the quota
of oxaloacetate, since this intermediate of the tricarboxylic acid
cycle (TCA) is labile at body temperature and cannot be accu-
mulated in the mitochondrial matrix. Hence it is necessary to
refurnish the TCA with oxaloacetate via the anaplerotic cycle that
derives it from glucose through ATP dependent carboxylation of
pyruvic acid by pyruvate carboxylase (Jitrapakdee et al., 2006).
This pathway is the only way to create oxaloacetate in mammals.
Once produced by the liver, KBs are used by tissues as a source
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of energy (Fukao et al., 2004; Veech, 2004; McCue, 2010): initially
BHB is converted back to AcAc that is subsequently transformed
into Acetoacetyl-CoA that undergoes a reaction producing two
molecules of Acetyl-CoA to be used in the Krebs cycle (Figure 2).
It is interesting to note that the KB are capable of producing
more energy than glucose due to the changes in mitochon-
drial ATP production induced by KB (Kashiwaya et al., 1994;
Sato et al., 1995; Veech, 2004). During fasting or KD glycaemia,
though reduced, remains within physiological levels (Seyfried and
Mukherjee, 2005; Paoli et al., 2011). This euglycemic response
to extreme conditions comes from two main sources: glucogenic
amino acids and glycerol liberated via lysis from triglycerides
(Vazquez and Kazi, 1994; Veldhorst et al., 2009). Glucogenic
amino acids (neoglucogenesis from amino acids) aremore impor-
tant during the earlier phases of KD, while the glycerol becomes
fundamental as the days go by. Thus, the glucose derived from
glycerol (released from triglyceride hydrolysis) rises from 16%
during a KD to 60% after a few days of complete fasting (Vazquez
and Kazi, 1994). According to Bortz (1972) 38% of the new
glucose formed from protein and glycerol is derived from glyc-
erol in the lean while 79% in the obese (Bortz et al., 1972). It
is important to note that during physiological ketosis (fast or
very low calorie ketogenic diets) ketonemia reaches maximum
levels of 7–8mmol/L with no change in blood pH, while in
uncontrolled diabetic ketoacidosis blood concentration of KBs
can exceed 20mmol/L with a consequent lowering of blood pH
(Robinson and Williamson, 1980; Cahill, 2006) (Table 1).
We can say that no species, including humans, could have sur-
vived for millions of years without the ability to withstand brief
periods of hunger or starvation (Amen-Ra, 2006). These periods
of fasting are themselves ketogenic (McCue, 2010) during which
the concentrations of insulin and glucose decrease while that
of glucagon increases in the attempt to maintain normal blood
glucose levels. When the body passes from a condition of food
abundance to one of deprivation (or else via VLCKD simulated
deprivation), there is, with a slight delay, an increase in the con-
centration of free FAs as well as KB in the blood. Thus, from this
point of view KD could be compared to caloric restriction for
fasting. These manipulations of nutrients, both in quantity and
quality, seem to not only act on blood glucose/KB level but also
to promote changes in metabolic pathways and cellular signaling.
How this kind of metabolic condition (ketosis) can affect satiety
and hunger mechanisms is still a matter of debate.
EFFECTS OF KETOSIS ON HUNGER AND SATIETY
Although convincing, the bulk of evidence in relation to
the inhibitory effects of ketosis on appetite is still anecdotal.
Preliminary scientific reports seem to support this phenomenon,
and the evidence shows that KD is more effective, at least in
the short/medium-term, on fat loss (Paoli, 2014). It was demon-
strated that diet-induced weight loss leads to changes in energy
Table 1 | Blood levels during a normal diet, ketogenic diet, and
diabetic ketoacidosis (Paoli et al., 2012).
Blood Normal Ketogenic Diabetic
levels diet diet ketoacidosis
Glucose (mg/dL) 80–120 65–80 >300
Insulin (μU/L) 6–23 6.6–9.4 ∼= 0
KB conc (mmol/L) 0.1 7–8 >25
pH 7.4 7.4 <7.3
FIGURE 2 | A reduced availability of dietary carbohydrates leads to an
increased liver production of KBs. The liver cannot utilize KBs because it
lacks the mitochondrial enzyme succinyl-CoA: 3-ketoacid (oxoacid) CoA
transferase (SCOT) necessary for activation of acetoacetate to acetoacetyl
CoA. KBs are utilized by tissues, in particularly by brain. KBs enter the citric acid
cycle after being converted to acetyl CoA by hydroxybutyrate dehydrogenase
(HBD), succinyl-CoA: 3–CoA transferase (SCOT), and methylacetoacetyl CoA
thiolase (MAT). Modified from Owen (2005), Paoli et al. (2014).
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expenditure and in appetite-regulating hormones that facili-
tate weight regain and the return to initial energy homeostasis
(Sumithran et al., 2011). This response to alteration of energy
balance nullifies the success of many dietary approaches. It is
well-known that the long-term success of a nutritional approach
is defined by the amount of weight regain and is the main
problem regarding the so-called weight cycling or “yo-yo” effect
(Jeffery, 1996). A recent study by our group has demonstrated
that a brief ketogenic period, if followed by a longer period of
correct Mediterranean diet could avoid this yo-yo effect (Paoli
et al., 2013). During the ketogenic period subjects reported less
hunger, confirming previous studies (Nickols-Richardson et al.,
2005; Johnston et al., 2006; Johnstone et al., 2008) on hunger-
suppression effect of ketogenic diet. Despite these clinical find-
ings, the mechanisms of action of ketosis on appetite reduction
are still not completely understood. Clinical results are suggestive
of both direct and indirect (via modifications of hunger-related
hormones concentration) actions of KBs on appetite (Sumithran
et al., 2013).
ROLE OF KETOSIS IN NUTRIENT-SPECIFIC CONTROL OF HUNGERS AND
SATIETY
The findings of a stable (Chearskul et al., 2008) or slightly
increased response (Sumithran et al., 2013) of post-prandial FFA
after KD can be viewed in the nutrient-static context. Elevated
circulating FFA may actually reduce food intake and glucose
production through actions on specific hypothalamic neurons
(Obici et al., 2003). It has been suggested that this effect could be
mediated by the increase of cellular concentration of long-chain
FAs-CoA in the arcuate nuclei of the hypothalamus (Obici et al.,
2003).
Brain glucose and KB uptake was investigated in rats subjected
to mild experimental ketonemia induced by 2 weeks on the KD
or by 48 h fasting. To test this, researchers developed a carbon-11
labeled AcAc (11)C-AcAc for PET use. They found in rats that
after 10 days of KD (11)C-AcAc brain uptake increased up to
8-fold, an increase comparable to those measured after 48 h of
fasting (Pifferi et al., 2008).
The BBB, largely formed by the brain capillary endothelial
cells, provides a protective barrier between the systemic blood and
the extracellular environment of the CNS. Passage of FAs from the
blood to the brain may occur either by diffusion or by
proteins that facilitate their transport. Studies indicate that
FATP-1 and FATP-4 are the predominant FA transport proteins
expressed in the BBB based on human and mouse expression
studies (Mitchell et al., 2011).
As a matter of fact, in animal models intracerebroventricu-
lar injections of long-chain FA reduced hypothalamic expression
of NPY. NPY is an important orexogenic neuropeptide that is
a downstream target of leptin and insulin in the hypothalamus.
In some forms of hyperphagic obesity, characterized by elevated
plasma leptin and insulin levels, the lack of action of insulin
on NPY expression could explain the pathological condition.
Central administration of oleic acid, fatty-acid synthase, or CPT-1
inhibitors prevents the rise in hypothalamic NPY mRNA induced
by fasting (Obici et al., 2003). But glucose level is also involved in
KD’s food control mechanisms. According to glucostatic theory
(Mayer, 1955) data indicates that ketosis did not influence FA glu-
cose but instead stimulated the elevation of post-prandial glucose
(Sumithran and Proietto, 2013) in non-diabetic subjects, while in
diabetics there was a reduction of fasting glucose (Westman et al.,
2008). It is important to note that carbohydrate availability may
increase cellular levels of long-chain FA-CoA through an increase
of malonyl-CoA, which inhibits oxidation of FAs.
Another product of elevated levels of free FA is polyun-
saturated FA (PUFA). The potential ability of PUFA to block
seizure activity in the brain is speculated to be associated with
KD. Some mechanisms are thought to be a direct inhibition
of voltage-gated sodium and calcium channels, modulation of
a lipid-sensitive potassium channel, the activity of the sodium
pump to limit neuronal excitability, or the induction of expres-
sion and activity of proteins in the mitochondria, thereby induc-
ing a neuroprotective effect by partially inhibiting the production
of reactive oxygen species (ROS) (Bough and Rho, 2007; Paoli
et al., 2014).
ROLE OF KETOSIS ON NEUROENDOCRINE CONTROL OF HUNGERS AND
SATIETY
The discovery of many appetite-related hormones provided
molecular basis for appetite control, decreasing the relevance of
the metabolites hypothesis (Karatsoreos et al., 2013). Recently,
Sumithran et al. demonstrated that there is a long-term per-
sistence of changes in some peripheral hormones involved in
food control (Sumithran et al., 2011). In this study, they found
a significant difference in mean levels of many food intake-
related hormones 1 year after the cessation of weight loss via the
hypocaloric diet. There was a long lasting decrease of anorexigenic
compounds: leptin, PYY, cholecystokinin, insulin, and pancre-
atic peptide and an increase of the orexigenic molecule ghrelin.
Moreover, they found that hunger remained elevated 1 year after
diet cessation. In a successive study the same group investigated
hunger-related hormones after 8 weeks of KD, demonstrating
that during ketosis the increase of ghrelin (a strong stimulator of
appetite) was suppressed (Sumithran et al., 2013). These results
are consistent with those of Ratliff et al (Ratliff et al., 2009), who
found no significant change in fasting plasma ghrelin after 12
weeks of VLCD.
Moreover, in the above study of Sumithran et al. (2013), ketosis
maintains post-prandial secretion of CCK as previously demon-
strated by other researchers (Chearskul et al., 2008). Note that the
orexigenic effect of BHB is blocked by transection of the com-
mon hepatic branch of the vagus nerve (Langhans et al., 1985).
The hepatic branch contains fibers from the proximal small intes-
tine, stomach and pancreas, and is sensitive to CCK (Horn and
Friedman, 2004); ghrelin signals to brain are also transmitted via
vagus nerve (Habara et al., 2014). Thus, the effects of ketosis on
these two appetite-related hormones could be one of the many
factors related to the effects of such nutritional regimen on food
control.
Many questions about the role of such an important interme-
diate of lipid metabolism remains unanswered, e.g., the role of
BHB in food control. For example, whether or not BHB could
act as a satiety signal in the brain, considering its role in energy
supply to CNS. We have to consider that the effects of KBs on
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hunger reduction can only be seen after many days following fast-
ing or KD initiation (Paoli et al., 2010); this is consistent with
the abovementioned threshold of brain utilization of KB as an
energy source, i.e., 4mmol/L (Veech, 2004), which is close to
the Km for the monocarboxylate transporter (Leino et al., 2001).
During the first days of fasting or KD there is a rise of BHB
and adiponectin concentrations (Halberg et al., 2005). One of
the putative causes of hunger in starved humans may be due—
together with other causes—to adiponectin. When adiponectin
binds to its receptor AdipoR1, AMP-activated protein kinase
(AMPK) is phosphorylated in the ARC of the hypothalamus
(Valassi et al., 2008). The increase of AMPK activity in the
hypothalamus may increase food intake and hepatic glucose out-
put inmice while the decrease seems to reduce food intake (Zhang
et al., 2009). KDs can also act similarly to a caloric restriction on
AMPK (Newman and Verdin, 2014). Interestingly, AMPK seems
to have opposing actions on the liver, muscle tissues and the brain:
in liver and muscle AMPK activation increases FA oxidation by
decreasingmalonyl-CoA concentrations (Malonyl-CoA is the first
intermediate in the lipogenic pathway and is also an inhibitor
of carnitine palmitoyltransferase-1 (CPT-1). CPT-1 activity can
be limiting for FA oxidation), through the inactivation of the
acetyl-CoA carboxylase 1 (ACC1). AMPK can also increase the
activity of malonyl-CoA decarboxylase (MCD), which enhances
the decrease of malonyl-CoA levels.
On the contrary, in the brain, as mentioned above, the increase
of AMPK activity leads to higher food intakes. But the effect of
AMPK in the brain is more complicated; mice lacking AMPKa2
in pro-opiomelanocortin neurons develop obesity, while the defi-
ciency of AMPKa2 in agouti-related protein neurons results in
an age-dependent phenotype. Thus, the conclusion is that even
while AMPK is a regulator of hypothalamic functions, it does not
act as a signal for energy deficit or excess (Claret et al., 2007).
However, the picture is more complex than this (Figure 3); BHB
induces AgRP expression while increasing ATP and inhibiting
AMPK phosphorylation (Cheng et al., 2008). Moreover, Laeger
and colleagues have recently demonstrated that under physiolog-
ical conditions BHB decreases AMPK phosphorylation and AgRP
mRNA expression in GT1-7 hypothalamic cells (Laeger et al.,
2012).
Another mechanism that could be involved in food-regulation
during KD is the gamma aminobutyric acid (GABA) and glu-
tamate regulation. Wu et al. demonstrated that GABAergic sig-
naling from the NPY/AgRP neurons to the parabrachial nucleus
(located in the dorsolateral part of the pons) is involved in many
regulatory sensory stimuli including taste and gastric distension,
regulate feeding behavior. GABA signaling seems to prevent ani-
mals from anorexia when AgRP neurons were destroyed (Wu
et al., 2009). These findings are yet another contradictory aspect
of KDs and food behavior; ketosis should increase the availabil-
ity of glutamate (via diminution of transamination of glutamate
to aspartate) and therefore increase GABA and glutamine lev-
els; moreover, in ketosis, the brain imports a huge amount of
acetate and converts it through glia into glutamine (an impor-
tant precursor of GABA) (Yudkoff et al., 2008). The result of
these mechanisms, together with the increased mitochondrial
metabolism and flux through the TCA cycle, is an increased
synthesis of glutamine and a “buffering” of glutamate. These
results are not consistent with the well-documented anorexigenic
effect of KDs, and therefore the GABA hypothesis cannot be taken
into account despite the mild euphoria often reported during a
KD that is probably due to the action of BHB (Brown, 2007) and
can help to reduce appetite.
OTHER POSSIBLE MECHANISMS
GUT MICROBIOTA
It is known that different dietary components exert some effects
on gut microbiome composition, mainly in relation to obesity
and inflammatory states. In general, a Mediterranean diet has a
positive effect while a high-protein diet seems to have detrimen-
tal effects due to putrefaction phenomena (Lopez-Legarrea et al.,
2014; Flint et al., 2015). Few data are available at this time about
the effects of KD on gut microbiota. For example, a study by
Crawford et al. (2009) investigated the regulation of myocardial
ketone bodymetabolism by the gut microbiota and demonstrated
that, during fasting, the presence of gut microbiota improved the
supply of ketone bodies to the heart where KBs were oxidized. In
the absence of a microbiota, low levels of KB was associated with
a related increase in glucose utilization, but heart weight was still
significantly reduced. The myocardial-mass reduction was com-
pletely reversed in germ-free mice feeded with a ketogenic diet.
Regarding food control we can hypothesize that the particular
metabolic state of ketosis could provide some benefit to weight
and food control via synergic actions between butyrate produc-
tion by gut bacteria and circulating high blood ketones (Sanz
et al., 2015).
REACTIVE OXYGEN SPECIES
As is in the case of GABA, the intracellular reactive oxygen
species (ROS) hypothesis works against the hunger-suppressive
role of KD: it has been demonstrated that the hypothalamic
ROS increase through NADPH oxidase is required for the eating-
inhibitory effect of insulin (Jaillard et al., 2009); moreover it
FIGURE 3 | Effects of ketone bodies on AMP-activated protein kinase
(AMPK) actions in different tissues.
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FIGURE 4 | Scheme of orexigenic and anorexigenic effects of ketosis. The
picture is highly schematic. For more details please see the text. AMPK,
AMP-activated protein kinase; CCK, cholecystokinin; GABA,
gamma-aminobutyric acid; BHB, β-hydroxybutyric acid; FFA, free fatty acids;
ROS, reactive oxygen species; NPY, neuropeptide Y; AgRP, agouti
gene-related protein.
has been demonstrated that there is a ROS-dependent signal-
ing pathway within the hypothalamus that regulates the energy
homeostasis, and that activation of ROS-sensitive mechanisms
could be sufficient to promote satiety (Benani et al., 2007). On
the other side, KBs decreases mitochondrial production of ROS
by increasing NADH oxidation in the mitochondrial respiratory
chain (Maalouf et al., 2007).
CONCLUSIONS
Although the hunger-reducing effect of KD is well-documented,
its main mechanisms of action are still elusive. The global picture
is complicated by the contradictory role of ketosis on anorexi-
genic and orexigenic signals (summarized in Figure 4). Ketones
(mainly BHB) can act both orexigenically or anorexigenically.
In the orexigenic mechanism, it increases the circulating level
of adiponectin, increasing brain GABA and AMPK phospho-
rylation and decreasing brain ROS production. The anorexi-
genic mechanism triggers a main normal glucose meal response,
increasing circulating post-meal FFA (thus reducing cerebral
NPY), maintaining CCK meal response and decreasing circu-
lating ghrelin. It can be postulated that the net balance of the
contrasting stimuli results in a general reduction of perceived
hunger and food intake. More studies are needed to explore
the mechanism of potential beneficial effects of KD on food
control.
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